Oncotarget

Reviews:

Important roles of P2Y receptors in the inflammation and cancer of digestive system

Han-Xing Wan, Jian-Hong Hu, Rei Xie, Shi-Ming Yang and Hui Dong _

PDF  |  HTML  |  How to cite

Oncotarget. 2016; 7:28736-28747. https://doi.org/10.18632/oncotarget.7518

Metrics: PDF 2360 views  |   HTML 3621 views  |   ?  


Abstract

Han-Xing Wan1, Jian-Hong Hu1, Rei Xie1, Shi-Ming Yang1 and Hui Dong1,2

1 Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, P.R. China

2 Division of Gastroenterology, Department of Medicine, School of Medicine, University of California, San Diego, California, USA

Correspondence to:

Hui Dong, email:

Keywords: P2Y receptors, digestive inflammation, digestive cancer

Received: November 04, 2015 Accepted: February 05, 2016 Published: February 19, 2016

Abstract

Purinergic signaling is important for many biological processes in humans. Purinoceptors P2Y are widely distributed in human digestive system and different subtypes of P2Y receptors mediate different physiological functions from metabolism, proliferation, differentiation to apoptosis etc. The P2Y receptors are essential in many gastrointestinal functions and also involve in the occurrence of some digestive diseases. Since different subtypes of P2Y receptors are present on the same cell of digestive organs, varying subtypes of P2Y receptors may have opposite or synergetic functions on the same cell. Recently, growing lines of evidence strongly suggest the involvement of P2Y receptors in the pathogenesis of several digestive diseases. In this review, we will focus on their important roles in the development of digestive inflammation and cancer. We anticipate that as the special subtypes of P2Y receptors are studied in depth, specific modulators for them will have good potentials to become promising new drugs to treat human digestive diseases in the near future.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 7518